Home » Newsletters » BioWorld Science

BioWorld Science

July 21, 2008

View Archived Issues

NeuroHealing receives grant from FDA for development of NH-001

Adjuvanted DNA vaccination against H5N1 influenza induces antibody response

Experimental lupus improved by bortezomib treatment

New anticancer agents described in recent patent literature

Phase II study of MBP-8298 clears DSMB review

Irribow approved in Japan for irritable bowel syndrome in men

Astellas Pharma's Graceptor approved in Japan for prevention of organ rejection

Nasonex receives Japanese approval for treatment of allergic rhinitis in adults

Raptor enters collaboration with UC for phase IIa clinical trial of cysteamine in NASH

Novartis to initiate phase III trial of Antisoma's ASA-404 in NSCLC

EpiCept and GNI enter license agreement for EP-1013

Boehringer licenses drug targets under autoimmune collaboration with Galapagos

MRCT and Biolex successfully complete collaboration to humanize BLX-301

sanofi-aventis to collaborate with Johns Hopkins University on respiratory diseases

ImmuneRegen reports results from genotoxicity studies of Homspera

Roche's novel Aurora kinase inhibitor shows promising preclinical profile

U.K. Ministry of Defense to initiate animal efficacy studies of ALS-886 in lung injury

Study investigates cardiac safety profile of antimuscarinic drugs for overactive bladder

Bradmer reports progression-free survival data from phase II trials of Neuradiab in GBM

Biovest announces results for BiovaxID in non-Hodgkin's lymphoma trial

EMEA grants orphan medicinal product designation to ProtAffin's PA-401

Hemantane improves symptoms of Parkinson's disease in an open-label study

Merrion enters next stage of oral drug collaboration program with Novo Nordisk

Teva signs definitive agreement to acquire Barr

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...